Yin Dan-Dan, Yang Mo, Wang Yun-Lai, Liu Hao-Kun, Zhou Min, Xu Fan
School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China.
Zhongguo Zhong Yao Za Zhi. 2018 Oct;43(19):3893-3898. doi: 10.19540/j.cnki.cjcmm.20180703.007.
Ligustrazine is an important active ingredient of the traditional Chinese medicine Chuanxiong Rhizoma, but its content is a controversial topic. The endophytes of medicinal plants have the ability to produce the same active substances as the host, so this report focused on the endophytic Bacillus subtilis, to study the origin of ligustrazine in Chuanxiong Rhizoma preliminarily by inoculating the isolated endophytic B. subtilis to the Chuanxiong Rhizoma medium for solid state fermentation. Tissue grinding method was used to isolate the endogenetic B. subtilis. The morphological features, conventional physiological and biochemical reactions and 16S rRNA molecular techniques were combined to identify the endogenetic strains. Then, the strains that grew well in the medicinal matrix of Chuanxiong Rhizoma were screened out for further fermentation studies. The solid-state fermentation was performed at 37 °C for 30 d using Chuanxiong Rhizoma fermentation medium (40 g Chuanxiong Rhizoma powder, 100 mL sterile water, 121 °C, sterilization for 25 minutes). UPLC was used to detect the contents of ligustrazine, acetoin in the Chuanxiong Rhizoma fermentation medium and Chuanxiong Rhizoma. All the five strains were Gram-positive and had spores. Phylogenetic analysis of the 16S rRNA sequence showed that the endophytes were B. subtilis. The results of UPLC showed that ligustrazine was detected in the Chuanxiong Rhizoma fermentation medium inoculated with endogenetic B. subtilis LB3, LB3-2-1, LB4, LB5 and LB6-2, while not detected neither in blank Chuanxiong Rhizoma fermentation medium nor in Chuanxiong Rhizoma. This study showed that the endogenetic B. subtilis of Ligusticum chuanxiong Hort. can make use of Chuanxiong Rhizoma fermentation medium to produce ligustrazine. Endogenetic B. subtilis has a certain correlation with the accumulation of ligustrazine in Rhizoma Chuanxiong. We speculate that the ligustrazine may be derived from the catabolism of endogenetic B. subtilis in Ligusticum chuanxiong.
川芎嗪是传统中药川芎的重要活性成分,但其含量是一个有争议的话题。药用植物内生菌具有产生与宿主相同活性物质的能力,因此本报告聚焦于内生枯草芽孢杆菌,通过将分离得到的内生枯草芽孢杆菌接种到川芎培养基中进行固态发酵,初步研究川芎中川芎嗪的来源。采用组织研磨法分离内生枯草芽孢杆菌。结合形态特征、常规生理生化反应及16S rRNA分子技术对内生菌株进行鉴定。然后,筛选出在川芎药用基质中生长良好的菌株进行进一步发酵研究。使用川芎发酵培养基(40 g川芎粉、100 mL无菌水,121℃,灭菌25分钟)在37℃下进行30天的固态发酵。采用超高效液相色谱法检测川芎发酵培养基和川芎中川芎嗪、乙偶姻的含量。所有五株菌株均为革兰氏阳性且有芽孢。16S rRNA序列的系统发育分析表明这些内生菌为枯草芽孢杆菌。超高效液相色谱法结果显示,接种内生枯草芽孢杆菌LB3、LB3-2-1、LB4、LB5和LB6-2的川芎发酵培养基中检测到川芎嗪,而空白川芎发酵培养基和川芎中均未检测到。本研究表明川芎内生枯草芽孢杆菌能够利用川芎发酵培养基产生川芎嗪。内生枯草芽孢杆菌与川芎中川芎嗪的积累有一定相关性。我们推测川芎嗪可能来源于川芎内生枯草芽孢杆菌的分解代谢。